Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7179

1.

Neutral polymers as coatings for high resolution electrophoretic separation of Aβ peptides on glass microchips.

Mesbah K, Verpillot R, Chiari M, Pallandre A, Taverna M.

Analyst. 2014 Oct 30. [Epub ahead of print]

PMID:
25356444
[PubMed - as supplied by publisher]
2.

Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease.

Mattsson N, Insel PS, Landau S, Jagust W, Donohue M, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner M; Alzheimer's Disease Neuroimaging Initiativea.

Ann Clin Transl Neurol. 2014 Aug;1(8):534-43. doi: 10.1002/acn3.81. Epub 2014 Jul 19.

PMID:
25356425
[PubMed]
3.

Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment.

Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC, Macaulay SL, Masters CL, Hill AF.

Mol Psychiatry. 2014 Oct 28. doi: 10.1038/mp.2014.127. [Epub ahead of print]

PMID:
25349172
[PubMed - as supplied by publisher]
4.

Plasma leptin levels are not predictive of dementia in patients with mild cognitive impairment.

Oania R, McEvoy LK.

Age Ageing. 2014 Oct 27. pii: afu160. [Epub ahead of print]

PMID:
25349150
[PubMed - as supplied by publisher]
5.

Primary age-related tauopathy (PART): a common pathology associated with human aging.

Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL 3rd, Wisniewski T, Woltjer RL, Yamada M, Nelson PT.

Acta Neuropathol. 2014 Oct 28. [Epub ahead of print]

PMID:
25348064
[PubMed - as supplied by publisher]
6.

Cortical thickness and semantic fluency in Alzheimer's disease and mild cognitive impairment.

Eastman JA, Hwang KS, Lazaris A, Chow N, Ramirez L, Babakchanian S, Woo E, Thompson PM, Apostolova LG.

Am J Alzheimers Dis (Columbia). 2013;1(2):81-92.

PMID:
25346870
[PubMed]
Free PMC Article
7.

White Matter Integrity Determined With Diffusion Tensor Imaging in Older Adults Without Dementia: Influence of Amyloid Load and Neurodegeneration.

Kantarci K, Schwarz CG, Reid RI, Przybelski SA, Lesnick TG, Zuk SM, Senjem ML, Gunter JL, Lowe V, Machulda MM, Knopman DS, Petersen RC, Jack CR Jr.

JAMA Neurol. 2014 Oct 27. doi: 10.1001/jamaneurol.2014.1482. [Epub ahead of print]

PMID:
25347157
[PubMed - as supplied by publisher]
8.

Identification and characterization of Aβ peptide interactors in Alzheimer's disease by structural approaches.

Philibert KD, Marr RA, Norstrom EM, Glucksman MJ.

Front Aging Neurosci. 2014 Oct 9;6:265. doi: 10.3389/fnagi.2014.00265. eCollection 2014.

PMID:
25346686
[PubMed]
Free PMC Article
9.

Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment.

Auning E, Selnes P, Grambaite R, Saltytė Benth J, Haram A, Løvli Stav A, Bjørnerud A, Hessen E, Hol PK, Muftuler Løndalen A, Fladby T, Aarsland D.

Acta Psychiatr Scand. 2014 Oct 25. doi: 10.1111/acps.12352. [Epub ahead of print]

PMID:
25346330
[PubMed - as supplied by publisher]
10.

Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease.

Altunoglu E, Guntas G, Erdenen F, Akkaya E, Topac I, Irmak H, Derici H, Yavuzer H, Gelisgen R, Uzun H.

Geriatr Gerontol Int. 2014 Oct 27. doi: 10.1111/ggi.12361. [Epub ahead of print]

PMID:
25345484
[PubMed - as supplied by publisher]
11.

Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model.

Cho SM, Kim HV, Lee S, Kim HY, Kim W, Kim TS, Kim DJ, Kim Y.

Sci Rep. 2014 Oct 27;4:6777. doi: 10.1038/srep06777.

PMID:
25345439
[PubMed - in process]
Free PMC Article
12.

DTI-MRI biomarkers in the search for normal pressure hydrocephalus aetiology: a review.

Hoza D, Vlasák A, Hořínek D, Sameš M, Alfieri A.

Neurosurg Rev. 2014 Oct 28. [Epub ahead of print]

PMID:
25345377
[PubMed - as supplied by publisher]
13.

Increased CSF APPs-α levels in patients with Alzheimer disease treated with acitretin.

Endres K, Fahrenholz F, Lotz J, Hiemke C, Teipel S, Lieb K, Tüscher O, Fellgiebel A.

Neurology. 2014 Oct 24. pii: 10.1212/WNL.0000000000001017. [Epub ahead of print]

PMID:
25344383
[PubMed - as supplied by publisher]
14.

Imaging Brain Metabolism and Pathology in Alzheimer's Disease with Positron Emission Tomography.

Shokouhi S, Claassen D, Riddle W.

J Alzheimers Dis Parkinsonism. 2014 Apr;4(2). pii: 143.

PMID:
25343059
[PubMed]
Free PMC Article
15.

2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.

Alzheimer's Association National Plan Milestone Workgroup, Fargo KN, Aisen P, Albert M, Au R, Corrada MM, DeKosky S, Drachman D, Fillit H, Gitlin L, Haas M, Herrup K, Kawas C, Khachaturian AS, Khachaturian ZS, Klunk W, Knopman D, Kukull WA, Lamb B, Logsdon RG, Maruff P, Mesulam M, Mobley W, Mohs R, Morgan D, Nixon RA, Paul S, Petersen R, Plassman B, Potter W, Reiman E, Reisberg B, Sano M, Schindler R, Schneider LS, Snyder PJ, Sperling RA, Yaffe K, Bain LJ, Thies WH, Carrillo MC.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S430-52. doi: 10.1016/j.jalz.2014.08.103.

PMID:
25341459
[PubMed - in process]
Free Article
16.

Longitudinal effects of metabolic syndrome on Alzheimer and vascular related brain pathology.

Lin F, Lo RY, Cole D, Ducharme S, Chen DG, Mapstone M, Porsteinsson A; Alzheimer's Disease Neuroimaging Initiative.

Dement Geriatr Cogn Dis Extra. 2014 Jun 28;4(2):184-94. doi: 10.1159/000363285. eCollection 2014 May.

PMID:
25337075
[PubMed]
Free PMC Article
17.

Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus.

Graff-Radford NR.

Neurology. 2014 Oct 21;83(17):1573-5. doi: 10.1212/WNL.0000000000000916.

PMID:
25332445
[PubMed - in process]
18.

Drugs developed for treatment of diabetes show protective effects in Alzheimer's and Parkinson's diseases.

Hölscher C.

Sheng Li Xue Bao. 2014 Oct 25;66(5):497-510.

PMID:
25331995
[PubMed - in process]
Free Article
19.

[Clinically validated molecular biomarkers of neurodegenerative dementia.]

Wiltfang J.

Nervenarzt. 2014 Oct 22. [Epub ahead of print] German.

PMID:
25331214
[PubMed - as supplied by publisher]
20.

Resistance Training Does not have an Effect on Cognition or Related Serum Biomarkers in Nonagenarians: A Randomized Controlled Trial.

Ruiz JR, Gil-Bea F, Bustamante-Ara N, Rodríguez-Romo G, Fiuza-Luces C, Serra-Rexach JA, Cedazo-Minguez A, Lucia A.

Int J Sports Med. 2014 Oct 20. [Epub ahead of print]

PMID:
25329433
[PubMed - as supplied by publisher]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk